The University of Chicago Header Logo

Connection

Michael Becker to Clinical Trials, Phase III as Topic

Back to Details
This is a "connection" page, showing publications Michael Becker has written about Clinical Trials, Phase III as Topic.
Michael Becker
Connection Strength
0.029
Clinical Trials, Phase III as Topic
  1. Infusion-related reactions with pegloticase, a recombinant uricase for the treatment of chronic gout refractory to conventional therapy. J Clin Rheumatol. 2014 Dec; 20(8):427-32.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.